Satsuma Pharmaceuticals, Inc. Annual Return On Equity in % from 2019 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Satsuma Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2022.
  • Satsuma Pharmaceuticals, Inc. Return On Equity for the quarter ending March 31, 2023 was -115 %, a 121% decline year-over-year.
  • Satsuma Pharmaceuticals, Inc. annual Return On Equity for 2022 was -102 %, a 141% decline from 2021.
  • Satsuma Pharmaceuticals, Inc. annual Return On Equity for 2021 was -42.4 %, a 21.4% increase from 2020.
  • Satsuma Pharmaceuticals, Inc. annual Return On Equity for 2020 was -53.9 %, a 5.45% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -102 -59.7 -141% Jan 1, 2022 Dec 31, 2022
2021 -42.4 +11.5 +21.4% Jan 1, 2021 Dec 31, 2021
2020 -53.9 +3.11 +5.45% Jan 1, 2020 Dec 31, 2020
2019 -57 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.